Azitra, Inc. (AZTR) stock
AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.61−0.02 (-3.03%)
Close on Nov 17, 2026Market cap $36.85MP/E –Yield –
Azitra cash
Cash and short-term investments held at the end of each period.
Azitra's cash was $6.73M at Jun 30, 2026. For fiscal 2025 it was $2.07M, down 54.6% from the year before. The highest annual figure on record is $8.04M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.07M | -54.6% |
| FY2024 | Dec 31, 2024 | $4.55M | +153.6% |
| FY2023 | Dec 31, 2023 | $1.80M | -48.6% |
| FY2022 | Dec 31, 2022 | $3.49M | -56.6% |
| FY2021 | Dec 31, 2021 | $8.04M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $6.73M | +543.4% |
| Q1 FY2026 | Mar 31, 2026 | $10.05M | +213.4% |
| Q4 FY2025 | Dec 31, 2025 | $2.07M | -54.6% |
| Q3 FY2025 | Sep 30, 2025 | $1.40M | -80.7% |
| Q2 FY2025 | Jun 30, 2025 | $1.05M | +30.2% |
| Q1 FY2025 | Mar 31, 2025 | $3.21M | +6.8% |
| Q4 FY2024 | Dec 31, 2024 | $4.55M | +153.6% |
| Q3 FY2024 | Sep 30, 2024 | $7.26M | +65.0% |
| Q2 FY2024 | Jun 30, 2024 | $803.08K | -87.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.00M | +63.7% |
| Q4 FY2023 | Dec 31, 2023 | $1.80M | -48.6% |
| Q3 FY2023 | Sep 30, 2023 | $4.40M | -25.9% |
| Q2 FY2023 | Jun 30, 2023 | $6.29M | +67.7% |
| Q1 FY2023 | Mar 31, 2023 | $1.83M | -77.2% |
| Q4 FY2022 | Dec 31, 2022 | $3.49M | – |
| Q3 FY2022 | Sep 30, 2022 | $5.94M | – |
| Q2 FY2022 | Jun 30, 2022 | $3.75M | – |
| Q4 FY2021 | Dec 31, 2021 | $8.04M | – |
See a number that looks wrong?